The Combination of Metformin and Disulfiram-Cu for Effective
Radiosensitization on Glioblastoma Cells
Rezaei N, Neshasteh-Riz A, Mazaheri Z, Koosha F, Hoormand M. The combination of metformin and disulfiram-cu for effective radiosensitization on glioblastoma cells. Cell J. 2020; 22(3): 263-272. doi: 10.22074/cellj.2020.6798.
Glioblastoma (GBM) is one of the devastating types of primary brain tumors with a negligible response to standard therapy. Repurposing drugs, such as disulfiram (DSF) and metformin (Met) have shown antitumor properties in different cell lines, including GBM. In the present study, we focused on the combinatory effect of Met and DSF-Cu on the induction of apoptosis in U87-MG cells exposed to 6-MV X-ray beams.
Materials and Methods
In this experimental study, the MTT assay was performed to evaluate the cytotoxicity of
each drug, along with the combinatory use of both. After irradiation, the apoptotic cells were assessed using the flow
cytometry, western blot, and real-time polymerase chain reaction (RT-PCR) to analyze the expression of some cell
death markers such as
The synergistic application of both Met and DSF had cytotoxic impacts on the U87-MG cell line and made
them sensitized to irradiation. The combinatory usage of both drugs significantly decreased the cells growth, induced
apoptosis, and caused the upregulation of
It seems that the synergistic application of both Met and DSF with the support of irradiation can remarkably restrict the growth of the U87-MG cell line. This may trigger apoptosis via the stimulation of the intrinsic pathway. The combinatory use of Met and DSF in the presence of irradiation could be applied for patients afflicted with GBM.